 Kamada Ltd. NASDAQ TASE: KMDA, a plasma-derived biopharmaceutical company, today announced that it will release financial results for the first quarter ended March 31, 2020, prior to the open of the U.S. financial markets on Monday, May 18, 2020. Kamada management will host an investment community conference call on Monday, May 18, at 8:30am Eastern Time to discuss these results and answer questions. Shareholders and other interested parties may participate in the conference call by dialing 877-407-0792 from within the U.S., 1-809-406-247 from Israel, or 201-689-8263 International and entering the conference identification number: 13699990. 